Clinical significance of EPHX2 deregulation in prostate cancer
Ming-Sheng Liu1, Hui Zhao2, Chen-Xiang Xu1, Ping-Bo Xie1, Wei Wang1, Ying-Yu Yang1, Wen-Hui Lee1,3, Yang Jin4, Hong-Qing Zhou1
1 The Second Ward of Urology, Qujing Affiliated Hospital of Kunming Medical University, Qujing 655000, China 2 Department of Urology, The First Affiliated Hospital of Kunming Medical University, Kunming 650332, China 3 Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China 4 Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo 0379, Norway
Correspondence Address:
Hong-Qing Zhou, The Second Ward of Urology, Qujing Affiliated Hospital of Kunming Medical University, Qujing 655000 China Yang Jin, Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo 0379, Norway
 Source of Support: None, Conflict of Interest: None DOI: 10.4103/aja.aja_34_20 PMID: 32687069
|